Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of…
CM-Path publishes Tissue Access Paper in JCPath
'Through my own experiences as a trainee academic pathologist, I have become aware of the rich tissue resources stored within…
UK contribution to global radiotherapy research shines out in recent review
'To mark the 150th birthday of Marie Curie, the ‘Godmother of Radiotherapy’, NCRI’s Radiotherapy Research Group (CTRad) reviewed key practice…
Harmonising image collection in cancer research
'Clinical trials rely increasingly on medical images to diagnose and stratify patients, with many studies using imaging end points as…
Read the CM-Path consensus statement on ‘What is the role of pathologists in the implementation of liquid biopsy technologies?’
'CM-Path Discovery workstream held ‘The Liquid Biopsy’ Symposium on March 8th 2018. Following the day members of CM-Path worked in…
Interview with Dr Paul Nankivell, NCRI Head & Neck Group trainee
'As well as being a member of our Head & Neck Group, Paul is also a Senior Clinical Lecturer and…
First NCRI trainees share their feedback on scheme
'In 2016 several trainees joined NCRI Groups, enabling them to actively contribute to the development of trials within their areas…
The CM-Path Biobanking Sample Quality Improvement Tool is now live!
'We are excited to announce that the CM-Path Biobanking Sample Quality Improvement Tool is now available for download from our…
Developing a consensus for the future of radiotherapy-drug research
'Despite increasing numbers of radiotherapy trials and rising recruitment, a continuing challenge has been increasing the number of trials evaluating…
Developing better cancer trials for non-small cell lung cancers
'A consortium established by NCRI CTRad and the NCRI Lung Group to address the lack of radiotherapy and drug combination…
CTRad: moving boldly into the next phase 2018-2021
'Since its inception in 2009, NCRI’s flagship radiotherapy initiative, the Clinical and Translational Radiotherapy Research Working Group (CTRad), has achieved…
NCRI Cancer CTU Group releases new guidelines
'Collaboration between clinical trials units (CTUs), working in partnership with clinical investigators (CIs), and pharmaceutical company partners is a key…